256840.KS · 한국비엔씨
South Korea · RS rating 60 · As of 2026-10-14
| Price | 2,935.00 KRW |
|---|---|
| 1-day change | +3.7% |
| RS rating (overall / 1M / 3M / 12M) | 60 / 82 / 80 / 19 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 28 / 25 / 24 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | -13.3% |
| Sales growth Q/Q | +18.7% |
| Distance from 52-week high | +51.5% |
| Market cap (USD) | $155.9M |